Kensuke Nagai

940 citations
24 papers · 768 indexed · h-index 13
Topics
Pneumonia and Respiratory Infections (15 papers)Antibiotics Pharmacokinetics and Efficacy (8 papers)Antibiotic Resistance in Bacteria (7 papers)

In The Last Decade

Kensuke Nagai

24 papers receiving 728 citations

Peers

Kensuke Nagai
Comparison fields: 5 of 55
  • Epidemiology 582
  • Molecular Medicine 235
  • Infectious Diseases 232
  • Microbiology 228
  • Pharmacology 190
Replace Federico Román with:
Federico Román Spain
E Vallée France
M. Daniels United Kingdom
Kirsi Gröndahl‐Yli‐Hannuksela Finland
Brian G. Spratt Australia
H. Pruul Australia
Takeshi Saika Japan
Jay Bergeron United States
Anna Skoczyńska Poland
Shah Jalal Sweden
Kensuke Nagai relative to Federico Román Spain Federico Román's profile →
Citations per field
00.5×1.5×2.1×
Federico Román · 1×
Citations per year

Countries citing papers authored by Kensuke Nagai

Since Specialization
Citations

This map shows the geographic impact of Kensuke Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Nagai more than expected).

Fields of papers citing papers by Kensuke Nagai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Nagai. The network helps show where Kensuke Nagai may publish in the future.

Co-authorship network of co-authors of Kensuke Nagai

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Nagai. A scholar is included among the top collaborators of Kensuke Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Nagai. Kensuke Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 34
3 55
4 8
5 2
6 7
7 130
8 9
9 122
10 38
11 12
12 108
13 29
14 21
15 5
16 9
17 16
18 46
19 18
20 2

About Kensuke Nagai

Kensuke Nagai is a scholar working on Molecular Medicine, Microbiology and Epidemiology, having authored 24 papers that have together received 768 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (15 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Molecular Medicine (235 citations), Microbiology (228 citations) and Epidemiology (582 citations). Kensuke Nagai has collaborated with scholars based in United States, Japan and Croatia. Frequent co-authors include Peter C. Appelbaum, Michael R. Jacobs, Todd A. Davies, Bonifacio Dewasse, Kimiko Ubukata, Keisuke Sunakawa, Reiko Kobayashi, Keiko Hasegawa, Naoko Chiba and Glenn A. Pankuch. Their work appears in journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026